AGEN
Agenus Inc

12,512
Mkt Cap
$154.74M
Volume
96,767.00
52W High
$7.34
52W Low
$1.38
PE Ratio
-2.14
AGEN Fundamentals
Price
$4.59
Prev Close
$4.55
Open
$4.63
50D MA
$4.13
Beta
1.94
Avg. Volume
454,231.91
EPS (Annual)
-$10.59
P/B
-0.54
Rev/Employee
$327,414.56
Loading...
Loading...
News
all
press releases
Agenus Inc. (NASDAQ:AGEN) Receives Average Rating of "Hold" from Analysts
Shares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have been given a consensus recommendation of "Hold" by the five brokerages that are presently covering the company, MarketBeat Ratings reports...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session...
Business Wire·9d ago
News Placeholder
Agenus Appoints Dr. Jos Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including Frances AAC
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the appointment of Jos Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias...
Business Wire·10d ago
News Placeholder
HC Wainwright Has Bullish Outlook for Agenus FY2025 Earnings
Agenus Inc. (NASDAQ:AGEN - Free Report) - Equities research analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Agenus in a note issued to investors on Tuesday...
MarketBeat·14d ago
News Placeholder
What is HC Wainwright's Estimate for Agenus Q1 Earnings?
Agenus Inc. (NASDAQ:AGEN - Free Report) - Analysts at HC Wainwright issued their Q1 2026 EPS estimates for Agenus in a research report issued on Tuesday, November 11th. HC Wainwright analyst E...
MarketBeat·15d ago
News Placeholder
Agenus (NASDAQ:AGEN) Issues Earnings Results, Misses Expectations By $0.69 EPS
Agenus (NASDAQ:AGEN - Get Free Report) announced its earnings results on Monday. The biotechnology company reported $1.94 EPS for the quarter, missing analysts' consensus estimates of $2.63 by...
MarketBeat·17d ago
News Placeholder
Agenus Shares Rise 8.67% On Q3 Results And Clinical Milestones
(RTTNews) - Agenus Inc. (AGEN) rose 8.67% to $4.3250, up $0.3450, after reporting third-quarter 2025 results and announcing key clinical and regulatory advances...
Nasdaq News: Markets·18d ago
News Placeholder
Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -26.24% and -71.95%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
Agenus Inc. (Nasdaq: AGEN) today reported quarterly results for the period ended September 30, 2025, and provided a business update. Highlights include governmentfunded, reimbursed compassionate...
Business Wire·18d ago
News Placeholder
Insights Ahead: Agenus's Quarterly Earnings
read more...
Benzinga·21d ago

Latest AGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.